Hologic's Cynosure division launches TempSure Envi

23rd January 2018

Hologic, Inc.

Enaie Azambuja

0 0

Hologic's Cynosure division has announced the launch of TempSure Envi – an FDA-cleared advanced radiofrequency device that minimises facial fine lines and wrinkles, tightens skin through soft tissue coagulation, and improves the appearance of cellulite. TempSure Envi is a simpler way for patients to maintain beautiful skin. The device heats the deep layers of skin to regenerate collagen and improve the appearance of cellulite and wrinkles.

Treatments are safe for all skin types and require no downtime, lasting between 30 and 60 minutes based on the area treated.

Unlike other radiofrequency devices, TempSure Envi has the distinct advantage of Therapeutic Logic Control (TLC) – a system that links treatment time with target temperature, allowing for consistent treatment temperatures and high patient comfort levels. In fact, 99% of patients who participated in a Cynosure in-house study reported a pain-free treatment experience.

"With a customer base looking to diversify their specialty offerings beyond laser and injectable treatments, we are enthusiastic about the opportunity to provide a radiofrequency platform as effective and versatile as TempSure Envi," said Kevin Thornal, Hologic's Division President, Cynosure.

"We also look forward to a variety of future TempSure FDA clearances including surgical and women's health capabilities, among others, meeting additional critical customer needs." TempSure Envi treatments will be demonstrated at this year's American Academy of Dermatology meeting in San Diego.